Skip to main content

Table 1 Patient characteristics (n = 94)

From: Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade

Characteristic

Value

Median (range) age at CRPC diagnosis (years)

76.0 (49–94)

Median (range) initial PSA level (ng/mL)

146.0 (4.10–10,672)

TNM classification at the diagnosis of prostate cancer

 

 T1

4

 T2

17

 T3

45

 T4

28

 N1

50

 M1

67

Gleason score at the diagnosis of prostate cancer

 

 6

2

 7

4

 8

15

 9

60

 10

10

 Unknown

3

  1. CRPC castration-resistant prostate cancer, PSA prostate-specific antigen; SD standard deviation